MAP Pharmaceuticals - Ownership and Business Overview

Life ScienceCompany

MAP Pharmaceuticals Ownership

Who owns MAP Pharmaceuticals?

MAP Pharmaceuticals is owned by Allergan. It was acquired on March 22, 2013.

Was MAP Pharmaceuticals formerly PE-backed?

Yes. MAP Pharmaceuticals was formerly owned by 1 private investor.

MAP Pharmaceuticals Business Overview

Where is MAP Pharmaceuticals headquartered?

MAP Pharmaceuticals is headquartered in Mountain View, California.

What sector is MAP Pharmaceuticals in?

MAP Pharmaceuticals is a life science company.

Life Science M&A Summary in 2013

Out of 60 sectors in the Mergr database, life science ranked 8 in number of deals in 2013. The largest life science acquisition in 2013 was Onyx Pharmaceuticals - which was acquired by Amgen for $10.4B.

Join Mergr to view all 191 acquisitions of life science companies in 2013, including 25 acquisitions by private equity firms, and 166 by strategics.

MAP Pharmaceuticals

MAP Pharmaceuticals, Inc.

2400 Bayshore Parkway, Suite 200,
Mountain View, California 94043
United States,
(650) 386-3100
www.mappharma.com

MAP Pharmaceuticals, Inc. is a specialty pharmaceutical company developing innovative therapies and inhalation delivery platforms to treat a broad spectrum of respiratory and systemic diseases.


 Subscribe to unlock this and 206,153
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 198K M&A Transactions
  • 202K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 80K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.